Monthly information on share capital and company voting rights

Rhea-AI Summary

Cellectis (Euronext Growth: CLLS) published its monthly information on share capital and voting rights as of 09/30/2025. The company reports a total number of shares of 100,325,229 and a total number of voting rights of 89,413,272. The disclosure follows Article 223-16 of the General Regulation of the French financial markets authority and lists investor and media contacts for further information.

News Market Reaction – CLLS

+12.57% 2.2x vol

16 alerts

+12.57% Session close to close

+24.7% Peak in 31 hr 54 min

$331.90M Market Cap

2.2x Rel. Volume

In the Oct 8 session, CLLS gained 12.57%, reflecting a significant positive market reaction. Argus tracked a peak move of +24.7% during that session. Our momentum scanner triggered 16 alerts that day, indicating notable trading interest and price volatility. Trading volume was elevated at 2.2x the daily average, suggesting notable buying interest.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, Oct. 07, 2025 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
09/30/2025	100,325,229	89,413,272

For further information on Cellectis, please contact:

Media contacts:

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contact:

Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com

Attachment

• Voting_Rights_PR_September_2025_EN

FAQ

What are Cellectis's total shares and voting rights as of 09/30/2025 (CLLS)?

As of 09/30/2025, Cellectis reports 100,325,229 total shares and 89,413,272 total voting rights.

Which listing and ISIN apply to Cellectis in the 09/2025 share capital update?

Cellectis is listed on Euronext Growth with ISIN FR0010425595.

Where can investors get more information about Cellectis share capital (CLLS)?

Investors can contact Arthur Stril, Chief Financial Officer & Chief Business Officer, via the provided investor relations email.

Does the 09/30/2025 release for Cellectis indicate any capital changes or transactions?

The publication only provides the total number of shares and voting rights as of the date and does not state any specific transactions.

Which regulatory article governs Cellectis's monthly share capital disclosure?

The disclosure is made under Article 223-16 of the General Regulation of the French financial markets authority.

Who are the media contacts listed in Cellectis's September 2025 voting rights notice?

Media contacts listed include Pascalyne Wilson and Patricia Sosa Navarro, with phone numbers and an email for media inquiries.